$ARDX
ARDELYX, INC. Stock $ardx

$ardx Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022012630 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$468.0K	$6.582M
YoY Change	-92.89%	442.62%
Cost Of Revenue	$85.00K	$1.000M
YoY Change	-91.5%
Gross Profit	$383.0K	$5.582M
YoY Change	-93.14%	360.18%
Gross Profit Margin	81.84%	84.81%
Selling, General & Admin	$19.34M	$17.13M
YoY Change	12.89%	139.93%
% of Gross Profit	5049.35%	306.9%
Research & Development	$8.851M	$20.46M
YoY Change	-56.73%	29.11%
% of Gross Profit	2310.97%	366.46%
Depreciation & Amortization	$232.0K	$422.0K
YoY Change	-45.02%	-14.23%
% of Gross Profit	60.57%	7.56%
Operating Expenses	$28.19M	$37.59M
YoY Change	-25.0%	137.23%
Operating Profit	-$27.81M	-$32.01M
YoY Change	-13.12%	47.02%
Interest Expense	$746.0K	$1.100M
YoY Change	-32.18%	-18.94%
% of Operating Profit
Other Income/Expense, Net	$484.0K	-$49.00K
YoY Change	-1087.76%	-106.51%
Pretax Income	-$28.07M	-$33.15M
YoY Change	-15.34%	48.19%
Income Tax	$2.000K	$1.000K
% Of Pretax Income
Net Earnings	-$28.07M	-$33.16M
YoY Change	-15.33%	48.19%
Net Earnings / Revenue	-5998.08%	-503.72%
Basic Earnings Per Share	-$0.21	-$0.34
Diluted Earnings Per Share	-$0.21	-$0.34
COMMON SHARES
Basic Shares Outstanding	130.9M shares	97.18M shares
Diluted Shares Outstanding	130.9M shares	97.18M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$89.70M	$178.2M
YoY Change	-49.66%	-20.16%
Cash & Equivalents	$47.08M	$84.07M
Short-Term Investments	$42.63M	$94.14M
Other Short-Term Assets	$16.64M	$21.40M
YoY Change	-22.24%	365.22%
Inventory	$3.487M
Prepaid Expenses
Receivables	$4.394M	$5.783M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$114.2M	$205.4M
YoY Change	-44.38%	-10.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.045M	$2.292M
YoY Change	-10.78%	-64.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change
Other Assets	$1.228M	$958.0K
YoY Change	28.18%	219.33%
Total Long-Term Assets	$15.18M	$4.917M
YoY Change	208.79%	-26.61%
TOTAL ASSETS
Total Short-Term Assets	$114.2M	$205.4M
Total Long-Term Assets	$15.18M	$4.917M
Total Assets	$129.4M	$210.3M
YoY Change	-38.46%	-10.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.030M	$5.378M
YoY Change	-6.47%	437.8%
Accrued Expenses	$16.67M	$17.00M
YoY Change	-1.92%	46.55%
Deferred Revenue		$2.723M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$26.14M	$16.70M
YoY Change	56.52%	125.68%
Total Short-Term Liabilities	$47.84M	$41.79M
YoY Change	14.48%	78.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$34.30M
YoY Change	-100.0%	-19.86%
Other Long-Term Liabilities	$17.38M	$3.300M
YoY Change	426.52%	135.71%
Total Long-Term Liabilities	$0.00	$37.60M
YoY Change	-100.0%	-14.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.84M	$41.79M
Total Long-Term Liabilities	$0.00	$37.60M
Total Liabilities	$65.22M	$79.48M
YoY Change	-17.95%	17.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$741.0M	-$587.9M
YoY Change	26.04%
Common Stock	$805.3M	$718.7M
YoY Change	12.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.19M	$130.8M
YoY Change
Total Liabilities & Shareholders Equity	$129.4M	$210.3M
YoY Change	-38.46%	-10.63%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$28.07M	-$33.16M
YoY Change	-15.33%	48.19%
Depreciation, Depletion And Amortization	$232.0K	$422.0K
YoY Change	-45.02%	-14.23%
Cash From Operating Activities	-$27.62M	-$44.22M
YoY Change	-37.54%	77.25%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$778.0K
YoY Change	-100.0%	3012.0%
Acquisitions
YoY Change
Other Investing Activities	$2.332M	$3.260M
YoY Change	-28.47%	-106.41%
Cash From Investing Activities	$2.332M	$2.485M
YoY Change	-6.16%	-104.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$5.921M	$34.27M
YoY Change	-82.72%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$63.00K	$34.77M
YoY Change	-100.18%	5783.25%
NET CHANGE
Cash From Operating Activities	-$27.62M	-$44.22M
Cash From Investing Activities	$2.332M	$2.485M
Cash From Financing Activities	-$63.00K	$34.77M
Net Change In Cash	-$25.35M	-$6.962M
YoY Change	264.13%	-90.75%
FREE CASH FLOW
Cash From Operating Activities	-$27.62M	-$44.22M
Capital Expenditures	$0.00	$778.0K
Free Cash Flow	-$27.62M	-$45.00M
YoY Change	-38.62%	80.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001437402
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36485
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ARDELYX, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1303944
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Fifth Avenue
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Waltham
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02451
CY2022Q1	dei	City Area Code CityAreaCode	510
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	745-1700
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2022Q1	dei	Trading Symbol TradingSymbol	ARDX
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	144598863	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47077000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72428000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	42627000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	44261000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4394000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	502000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	3487000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16640000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16458000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	114225000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	133649000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11910000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12752000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2045000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2362000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1228000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1150000	USD
CY2022Q1	us-gaap	Assets Assets	129408000	USD
CY2021Q4	us-gaap	Assets Assets	149913000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5030000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4277000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6304000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5422000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	26139000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	32264000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3592000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3492000	USD
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	6778000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7366000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	47843000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52821000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8812000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9748000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8563000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4727000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	65218000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	67296000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	136330360	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	136330360	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	130182535	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	130182535	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	14000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	805265000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	795540000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-741001000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-712930000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-88000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	64190000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82617000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	129408000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149913000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6582000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	85000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	1000000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8851000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20456000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19339000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17131000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	28275000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	38587000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27807000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-32005000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	746000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1100000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	484000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-49000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28069000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33154000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28071000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-33155000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130934795	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130934795	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97179241	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97179241	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28071000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-33155000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-82000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28153000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33158000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82617000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	83000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5921000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3722000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-82000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28071000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	64190000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	126112000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	478000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34272000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3087000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-33155000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	130811000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28071000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-33155000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	232000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	422000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	169000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	157000	USD
CY2022Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	47000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	77000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-15000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-157000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	842000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	607000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3722000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3087000	USD
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	15000	USD
CY2021Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	36000	USD
CY2022Q1	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-102000	USD
CY2021Q1	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	710000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	109000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3892000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5783000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3487000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	307000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13662000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	753000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-248000	USD
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	882000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1324000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-836000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-721000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1041000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7517000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3836000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1454000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27620000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44217000	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	27300000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	35370000	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	25763000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	32107000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	795000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	0	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	778000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2332000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2485000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	26971000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	33038000	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5921000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34272000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	83000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	498000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-63000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34770000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25351000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6962000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72428000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91032000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47077000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84070000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	741000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	963000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	450000	USD
CY2022Q1	ardx	Derivative Issued DerivativeIssued	375000	USD
CY2021Q1	ardx	Derivative Issued DerivativeIssued	0	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, the fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2022Q1	us-gaap	Investments And Cash InvestmentsAndCash	89700000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-741000000	USD
CY2022Q1	ardx	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	47078000	USD
CY2022Q1	ardx	Cash And Cash Equivalents Gross Unrealized Gains CashAndCashEquivalentsGrossUnrealizedGains	0	USD
CY2022Q1	ardx	Cash And Cash Equivalents Gross Unrealized Losses CashAndCashEquivalentsGrossUnrealizedLosses	1000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47077000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	42714000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	87000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	42627000	USD
CY2022Q1	ardx	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	89792000	USD
CY2022Q1	ardx	Cash Cash Equivalents And Investments Gross Unrealized Gains CashCashEquivalentsAndInvestmentsGrossUnrealizedGains	0	USD
CY2022Q1	ardx	Cash Cash Equivalents And Investments Gross Unrealized Losses CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses	88000	USD
CY2022Q1	us-gaap	Investments And Cash InvestmentsAndCash	89704000	USD
CY2021Q4	ardx	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	72428000	USD
CY2021Q4	ardx	Cash And Cash Equivalents Gross Unrealized Gains CashAndCashEquivalentsGrossUnrealizedGains	0	USD
CY2021Q4	ardx	Cash And Cash Equivalents Gross Unrealized Losses CashAndCashEquivalentsGrossUnrealizedLosses	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72428000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	44267000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	44261000	USD
CY2021Q4	ardx	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	116695000	USD
CY2021Q4	ardx	Cash Cash Equivalents And Investments Gross Unrealized Gains CashCashEquivalentsAndInvestmentsGrossUnrealizedGains	1000	USD
CY2021Q4	ardx	Cash Cash Equivalents And Investments Gross Unrealized Losses CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses	7000	USD
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	116689000	USD
CY2022Q1	ardx	Available For Sale Securities Debt Securities Current Contractual Maturities Maximum AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum	P1Y
CY2022Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	460000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2507000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	520000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	3487000	USD
CY2021Q4	ardx	Contract With Customer Gross To Net Sales Accruals ContractWithCustomerGrossToNetSalesAccruals	0	USD
CY2022Q1	ardx	Contract With Customer Gross To Net Sales Accrual Activity During Current Period ContractWithCustomerGrossToNetSalesAccrualActivityDuringCurrentPeriod	154000	USD
CY2022Q1	ardx	Contract With Customer Gross To Net Sales Accruals ContractWithCustomerGrossToNetSalesAccruals	154000	USD
CY2021Q1	ardx	Contract With Customer Gross To Net Sales Accruals ContractWithCustomerGrossToNetSalesAccruals	0	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28862000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1399000	USD
CY2022Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1324000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	26139000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12404000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13240000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	26139000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11910000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12752000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3592000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3492000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8812000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9748000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1321000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.069
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.069
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1064000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	673000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1058000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1565000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3234000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4440000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4589000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	252000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1432000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12404000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3592000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8812000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13836000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3722000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3087000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6476000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.16
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10417000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.00
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3535000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.98
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1006000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.18
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12946000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.34
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28071000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-33155000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130935000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130935000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97179000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97179000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13000000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13300000	shares
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD

Files In Submission

Name	View Source	Status
0001628280-22-012630-index-headers.html	Edgar Link	pending
0001628280-22-012630-index.html	Edgar Link	pending
0001628280-22-012630.txt	Edgar Link	pending
0001628280-22-012630-xbrl.zip	Edgar Link	pending
ardx-20220331.htm	Edgar Link	pending
ardx-20220331.xsd	Edgar Link	pending
ardx-20220331xex311.htm	Edgar Link	pending
ardx-20220331xex312.htm	Edgar Link	pending
ardx-20220331xex321.htm	Edgar Link	pending
ardx-20220331_cal.xml	Edgar Link	unprocessable
ardx-20220331_def.xml	Edgar Link	unprocessable
ardx-20220331_g1.jpg	Edgar Link	pending
ardx-20220331_htm.xml	Edgar Link	completed
ardx-20220331_lab.xml	Edgar Link	unprocessable
ardx-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
slrexitfeeagreement-ex102.htm	Edgar Link	pending
slrloanandsecurityagreemen.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARDX
ARDELYX, INC. Stock $ardx

2022 Q1 Form 10-Q Financial Statement

#000162828022012630 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARDX ARDELYX, INC. Stock $ardx

2022 Q1 Form 10-Q Financial Statement

#000162828022012630 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARDX
ARDELYX, INC. Stock $ardx